CD274 and neoplasm: A study by Liu et al. developed a dual-functional mesoporous silica nanoparticle (HMSN-ISO@ProA-PD-L1 Ab), which effectively modulated the tumor immune micro-environment by combining ISO and human PD-L1 antibodies.